| |
| |
|
| Insider
Information: |
Missling Christopher U |
| Relationship: |
President and CEO, Dir... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,250,210 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,388,405 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,250,210 |
|
|
| Total
Value |
$5,388,405 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -104.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Curis Inc |
CRIS |
Sr. VP, Strategic Plan... |
2004-01-20 |
0 |
2003-11-20 |
0 |
Premium* |
|
|
Anavex Life Sciences Corp |
AVXL |
President and CEO, Dir... |
2024-03-28 |
1,250,210 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2024-03-28 |
4 |
S |
$5.11 |
$374,972 |
D/D |
(73,380) |
1,250,210 |
0 |
% |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2024-03-28 |
4 |
OE |
$1.32 |
$96,862 |
D/D |
73,380 |
1,323,590 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2023-06-29 |
4 |
OE |
$1.60 |
$371,200 |
D/D |
232,000 |
1,250,210 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2023-06-28 |
4 |
S |
$7.98 |
$2,139,310 |
D/D |
(268,000) |
1,018,210 |
0 |
% |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2023-06-28 |
4 |
OE |
$1.60 |
$428,800 |
D/D |
268,000 |
1,286,210 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2021-06-29 |
4 |
OE |
$1.32 |
$68,138 |
D/D |
51,620 |
1,069,830 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2021-06-29 |
4 |
S |
$26.00 |
$1,342,120 |
D/D |
(51,620) |
1,018,210 |
0 |
% |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2018-03-07 |
4 |
AB |
$2.92 |
$3,971 |
D/D |
1,360 |
1,018,210 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2018-03-06 |
4 |
AB |
$2.73 |
$3,959 |
D/D |
1,450 |
1,016,850 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2018-03-05 |
4 |
AB |
$2.63 |
$3,945 |
D/D |
1,500 |
1,015,400 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
Director, President & CEO |
• • – |
2018-03-02 |
4 |
AB |
$2.41 |
$3,977 |
D/D |
1,650 |
1,013,900 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-10-25 |
4 |
AB |
$4.39 |
$1,646 |
D/D |
375 |
1,012,250 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-10-24 |
4 |
AB |
$4.92 |
$1,845 |
D/D |
375 |
1,011,875 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-10-19 |
4 |
AB |
$4.49 |
$1,684 |
D/D |
375 |
1,011,500 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-10-17 |
4 |
AB |
$4.27 |
$1,601 |
D/D |
375 |
1,011,125 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-10-13 |
4 |
AB |
$4.22 |
$3,165 |
D/D |
750 |
1,010,750 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-10-05 |
4 |
AB |
$4.30 |
$1,613 |
D/D |
375 |
1,010,000 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-10-02 |
4 |
AB |
$4.20 |
$1,575 |
D/D |
375 |
1,009,625 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-09-28 |
4 |
AB |
$4.21 |
$1,579 |
D/D |
375 |
1,009,250 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-09-26 |
4 |
AB |
$3.88 |
$1,455 |
D/D |
375 |
1,008,875 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-09-20 |
4 |
AB |
$4.23 |
$1,586 |
D/D |
375 |
1,008,500 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-09-18 |
4 |
AB |
$4.40 |
$1,650 |
D/D |
375 |
1,008,125 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-09-11 |
4 |
AB |
$4.81 |
$1,804 |
D/D |
375 |
1,007,375 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-09-07 |
4 |
AB |
$4.76 |
$1,785 |
D/D |
375 |
1,007,000 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
President and CEO |
• • – |
2017-09-05 |
4 |
AB |
$4.90 |
$1,838 |
D/D |
375 |
1,006,625 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
